Commerzbank Aktiengesellschaft’s Impax Laboratories, Inc. IPXL Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-29,990	Closed	-$711K	–	1039
2016 Q3	$711K	Buy	29,990 +14,116	+89%	+$379K	0.01%	486
2016 Q2	$457	Sell	15,874 -6,977	-31%	-$227K	﹤0.01%	701
2016 Q1	$732K	Buy	22,851 +6,863	+43%	+$241K	0.01%	578
2015 Q4	$684K	Buy	15,988 +1,207	+8%	+$48.2K	0.01%	771
2015 Q3	$520K	Buy	14,781 +5,975	+68%	+$269K	﹤0.01%	760
2015 Q2	$404K	Buy	8,806 +1,340	+18%	+$63.6K	﹤0.01%	1023
2015 Q1	$350K	Buy	+7,466	New	+$297K	﹤0.01%	1018

Other funds holding IPXL

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Commerzbank Aktiengesellschaft's IPXL Position: Q4 2016 in Review

Commerzbank Aktiengesellschaft sold out of Impax Laboratories, Inc. (IPXL) in Q4 2016, closing a stake of 29,990 shares — an estimated $711K sold.

Commerzbank Aktiengesellschaft first reported a position in IPXL in Q1 2015 and held it in 7 quarters. The position peaked at $732K in Q1 2016. 198 funds tracked by Wall St. Rank hold IPXL as of Q4 2016.

Commerzbank Aktiengesellschaft reported no remaining Impax Laboratories, Inc. position as of Q4 2016 after selling out during the quarter.
Commerzbank Aktiengesellschaft sold 29,990 Impax Laboratories, Inc. shares in Q4 2016, an estimated $711K.
Commerzbank Aktiengesellschaft first reported a position in Impax Laboratories, Inc. in Q1 2015 and held it in 7 quarters.
Commerzbank Aktiengesellschaft's Impax Laboratories, Inc. position peaked at $732K in Q1 2016.
198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2016.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2016, filed 7 Feb 2017.